Artificial intelligence (AI) scribes, which listen to a patient visit and draft the clinical note, have spread quickly across hospitals and physician practices. Patients, however, are now suing over the use of these scribes. Three proposed class actions, two in California and a new complaint dated November 3, 2026 in Pennsylvania, allege that health systems recorded exam-room conversations and sent them to an outside vendor without proper consent. Notably, each suit targets the health system that used the tool rather than the company that built it, and none is brought under HIPAA. The allegations have not been proven, but the theory can be brought in any state, and providers using these tools should review their consent practices now.
What Happened
All three cases involve the same ambient documentation tool, Abridge. Abridge is not a defendant.
-
Saucedo v. Sharp HealthCare (San Diego Superior Court, filed November 26, 2025).
A patient alleges that a Sharp clinic recorded his July 2025 physical without telling him or asking permission. He learned of the recording only by reading his visit notes online, which stated that he had been “advised” of the recording and had “consented.” He claims that statement was false and that Sharp used the boilerplate language knowing it had no reliable way to obtain consent. When he asked that the recording be deleted, he was told the vendor keeps audio for 30 days. The suit is brought under the California Invasion of Privacy Act (CIPA) and the Confidentiality of Medical Information Act (CMIA), among other claims, on behalf of a proposed class of more than 100,000 California patients recorded since April 1, 2025.
-
Washington v. Sutter Health (U.S. District Court, N.D. Cal., filed April 8, 2026).
Three patients allege that Sutter Health and affiliated MemorialCare entities used the same tool to record exam-room conversations and route them through outside systems without meaningful consent. They claim patients received no clear notice and that there was no consistent, system-wide consent process. The plaintiffs assert CIPA, CMIA, and federal Wiretap Act claims and seek a nationwide class.
-
H.R. v. Allegheny Health Network (Court of Common Pleas, Allegheny County, Pa., complaint dated November 3, 2026).
A patient proceeding under her initials, who discussed her mental health and addiction treatment during recorded visits, alleges she was told at most that an “AI tool” would be used. She claims she was not told that the full conversation would be recorded, sent to the vendor, and kept for the vendor to use in training its own products. The suit also names Highmark Health, the network’s parent and the patients’ insurer, alleging that it directed the rollout and benefits from the recordings through a shared prior authorization tool. The claims arise under Pennsylvania’s Wiretapping and Electronic Surveillance Control Act, an all-party consent statute, and common-law confidentiality and privacy theories, on behalf of everyone recorded through the tool at the network’s Pennsylvania facilities.
No court has ruled on the merits in any of these cases. The same consent theory is also being tested against general-purpose AI notetaking services, and it builds directly on the wave of website tracking pixel suits that hospitals have faced for several years. Ambient scribes may give plaintiffs an easier case to plead, because the alleged interception is the recording of an actual conversation.
Why Isn’t HIPAA Compliance Enough?
Many providers assume that a signed business associate agreement (BAA) with the vendor resolves the legal risk. HIPAA compliance remains essential, but the plaintiffs in these cases are not suing under HIPAA, which does not give patients a private right of action. Instead, they rely on state and federal wiretap and medical confidentiality laws. Those laws impose their own consent requirements, separate from HIPAA, and often let patients sue directly. A provider can have a BAA in place and still face claims under these laws.
Many of those laws also set fixed statutory damages for each violation, and plaintiffs argue that every recorded visit is a separate violation. Multiplied across thousands of visits, even modest per-violation amounts can add up quickly, which explains why these cases are being filed as class actions. Whether each recording counts separately, and whether a class can be certified, will be heavily contested.
What Allegations Should Providers Focus On?
-
Charts that say consent was obtained when it was not.
The most serious claim in Saucedo is not that consent was missing; it is that the medical record said consent was obtained when it was not. AI tools and EHR templates can automatically insert language such as “patient was advised and consented.” If that language appears in a chart with no matching consent event, it becomes evidence against the provider and may raise broader questions about the reliability of the record.
-
Telling patients “AI” will be used is not the same as consent.
The Pennsylvania complaint argues that consent extends only as far as the disclosure. A patient who agrees that her doctor may use a documentation aid has not, in the plaintiff’s view, agreed that an outside company may receive the conversation, keep it, and use it to build its own products. The complaint also faults the health system for not asking family members in the room, giving no signal that recording was active, and offering no real way to delete a recording.
Is This Only a California and Pennsylvania Issue?
-
No, this theory may travel.
Every state has its own wiretap and medical confidentiality laws. Providers in states that require everyone’s consent to record face the most direct exposure. But a one-party consent state is not a safe harbor: plaintiffs in the hospital tracking pixel cases have paired federal wiretap claims with state confidentiality and consumer protection claims to keep their cases alive.
-
The core exposure is the same everywhere.
The provider, not the vendor, is the defendant. Fixed damages per recording could turn routine visits into large class claims as the recordings capture sensitive conversations. Every visit recorded without clear, documented consent, including recordings already made, is a potential claim.
How Garfunkel Wild Can Help
Providers using ambient AI documentation tools should review their consent processes, chart documentation, and vendor agreements now. The right approach depends on the tool, the vendor’s terms, the care setting, and where patients are located, so there is no one-size-fits-all answer. Garfunkel Wild’s Litigation, Privacy, Cybersecurity, and AI teams can help providers assess their exposure, strengthen their practices, and respond if a claim is made.
Garfunkel Wild will continue to monitor these cases. Should you have any questions regarding the above, please contact the authors, the Garfunkel Wild attorney with whom you regularly work, or contact us at [email protected].